Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Protontherapy to maintain local control of head and neck paragangliomas

Protontherapy to maintain local control of head and neck paragangliomas ACTA ONCOLOGICA https://doi.org/10.1080/0284186X.2023.2201686 LETTER TO THE EDITOR a,b a,b a,b a,c d a,e Julie Chartier , Arnaud Beddok , Kim I. Cao , Loïc Feuvret , Philippe Herman ,Stephanie Bolle , a f g a,b a,b Farid Goudjil , Elisabeth Sauvaget , Olivier Choussy ,Remi Dendale and Valentin Calugaru a b Department of Radiation-Oncology, Proton Therapy Center of Orsay (CPO), Institut Curie, Orsay, France; Department of Radiation- c d Oncology, Institut Curie, Paris, France; Department of Radiotherapy, Pitie-Salpetriere University Hospital (APHP), Paris, France; Department of Head and Neck Surgery, Lariboisiere Hospital, Paris, France; Department of Radiation-Oncology, Gustave-Roussy Cancer Campus, Villejuif, f g France; Department of Otolaryngology, Saint-Joseph Hospital, Paris, France; Department of Otolaryngology, Institut Curie, Paris, France ARTICLE HISTORY Received 5 January 2023; accepted 6 April 2023 Introduction treated with protontherapy between July 2001 and May 2020, in the Institute Curie Proton Therapy Center in Orsay Paragangliomas are rare vascular neuroendocrine tumors (ICPO). One patient was excluded from our study because he that develop in neuroendocrine cell groups located along received photon-proton radiotherapy and died shortly after- vascular and nervous axes of the head, neck and neck. Their wards from chronic uncontrolled hepatitis. Therefore, seven- annual incidence is estimated http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Acta Oncologica Taylor & Francis

Protontherapy to maintain local control of head and neck paragangliomas

Download PDF
4 pages

Loading next page...
 
/lp/taylor-francis/protontherapy-to-maintain-local-control-of-head-and-neck-6PdOk5bRtx

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher
Taylor & Francis
Copyright
© 2023 Acta Oncologica Foundation
ISSN
1651-226X
eISSN
0284-186X
DOI
10.1080/0284186X.2023.2201686
Publisher site
See Article on Publisher Site

Abstract

ACTA ONCOLOGICA https://doi.org/10.1080/0284186X.2023.2201686 LETTER TO THE EDITOR a,b a,b a,b a,c d a,e Julie Chartier , Arnaud Beddok , Kim I. Cao , Loïc Feuvret , Philippe Herman ,Stephanie Bolle , a f g a,b a,b Farid Goudjil , Elisabeth Sauvaget , Olivier Choussy ,Remi Dendale and Valentin Calugaru a b Department of Radiation-Oncology, Proton Therapy Center of Orsay (CPO), Institut Curie, Orsay, France; Department of Radiation- c d Oncology, Institut Curie, Paris, France; Department of Radiotherapy, Pitie-Salpetriere University Hospital (APHP), Paris, France; Department of Head and Neck Surgery, Lariboisiere Hospital, Paris, France; Department of Radiation-Oncology, Gustave-Roussy Cancer Campus, Villejuif, f g France; Department of Otolaryngology, Saint-Joseph Hospital, Paris, France; Department of Otolaryngology, Institut Curie, Paris, France ARTICLE HISTORY Received 5 January 2023; accepted 6 April 2023 Introduction treated with protontherapy between July 2001 and May 2020, in the Institute Curie Proton Therapy Center in Orsay Paragangliomas are rare vascular neuroendocrine tumors (ICPO). One patient was excluded from our study because he that develop in neuroendocrine cell groups located along received photon-proton radiotherapy and died shortly after- vascular and nervous axes of the head, neck and neck. Their wards from chronic uncontrolled hepatitis. Therefore, seven- annual incidence is estimated

Journal

Acta Oncologica – Taylor & Francis

Published: Apr 3, 2023

References

  • Pheochromocytoma in Sweden 1958–1981
  • Evolving concepts in the management of jugular paraganglioma: a comparison of radiotherapy and surgery in 88 cases
  • Protonthérapie des carcinomes épidermoïdes des voies aérodigestives supérieures: de la physique à la clinique
  • Proton and X-ray radiation for head and neck paragangliomas
  • Protontherapy of head and neck paragangliomas: a monocentric study
  • Radiation dose constraints for organs at risk in neuro-oncology; the european particle therapy network consensus
  • Long-term results of irradiation for paraganglioma
  • Jugular and vagal paragangliomas: systematic study of management with surgery and radiotherapy
  • Clinical response and tumor control based on long-term follow-up and patient-reported outcomes in patients with chemodectomas of the skull base and head and neck region treated with highly conformal radiation therapy
  • Treatment of head and neck paragangliomas with external beam radiation therapy
  • Radiotherapy for benign head and neck paragangliomas: a 45-year experience
  • Paraganglioma of the head and neck region, treated with radiation therapy, a rare cancer network study
  • Proton therapy for head and neck paragangliomas: a single institutional experience
  • Long-Term outcomes in head and neck paragangliomas managed with Intensity-Modulated radiotherapy
  • Proton therapy for treatment of intracranial benign tumors in adults: a systematic review
  • Efficacy of stereotactic conformal radiotherapy vs conventional radiotherapy on benign and Low-Grade brain tumors: a randomized clinical trial
  • Incidence of second malignancies among patients treated with proton versus photon radiation
  • Projected second tumor risk and dose to neurocognitive structures after proton versus photon radiotherapy for benign meningioma
  • Risk of second brain tumor after conservative surgery and radiotherapy for pituitary adenoma: update after an additional 10 years